152 related articles for article (PubMed ID: 12393561)
1. Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors.
Tehranchi R; Fadeel B; Forsblom AM; Christensson B; Samuelsson J; Zhivotovsky B; Hellstrom-Lindberg E
Blood; 2003 Feb; 101(3):1080-6. PubMed ID: 12393561
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor inhibits Fas-triggered apoptosis in bone marrow cells isolated from patients with refractory anemia with ringed sideroblasts.
Schmidt-Mende J; Tehranchi R; Forsblom AM; Joseph B; Christensson B; Fadeel B; Zhivotovsky B; Hellström-Lindberg E
Leukemia; 2001 May; 15(5):742-51. PubMed ID: 11368434
[TBL] [Abstract][Full Text] [Related]
3. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
[TBL] [Abstract][Full Text] [Related]
4. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
Tehranchi R; Invernizzi R; Grandien A; Zhivotovsky B; Fadeel B; Forsblom AM; Travaglino E; Samuelsson J; Hast R; Nilsson L; Cazzola M; Wibom R; Hellström-Lindberg E
Blood; 2005 Jul; 106(1):247-53. PubMed ID: 15755901
[TBL] [Abstract][Full Text] [Related]
5. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum.
Gyan E; Frisan E; Beyne-Rauzy O; Deschemin JC; Pierre-Eugene C; Randriamampita C; Dubart-Kupperschmitt A; Garrido C; Dreyfus F; Mayeux P; Lacombe C; Solary E; Fontenay M
Leukemia; 2008 Oct; 22(10):1864-73. PubMed ID: 18615109
[TBL] [Abstract][Full Text] [Related]
7. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
8. The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells.
Schipperus MR; Sonneveld P; Lindemans J; Vink N; Vlastuin M; Hagemeijer A; Abels J
Leuk Res; 1990; 14(11-12):1019-25. PubMed ID: 1704083
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases.
Hellström-Lindberg E; Schmidt-Mende J; Forsblom AM; Christensson B; Fadeel B; Zhivotovsky B
Br J Haematol; 2001 Mar; 112(3):714-26. PubMed ID: 11260077
[TBL] [Abstract][Full Text] [Related]
10. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
11. Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.
Tehranchi R
Med Oncol; 2006; 23(1):37-49. PubMed ID: 16645228
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
13. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
Nikpour M; Pellagatti A; Liu A; Karimi M; Malcovati L; Gogvadze V; Forsblom AM; Wainscoat JS; Cazzola M; Zhivotovsky B; Grandien A; Boultwood J; Hellström-Lindberg E
Br J Haematol; 2010 Jun; 149(6):844-54. PubMed ID: 20408843
[TBL] [Abstract][Full Text] [Related]
15. Two pathways of apoptosis induced with all-trans retinoic acid and etoposide in the myeloid cell line P39.
Hassan Z; Fadeel B; Zhivotovsky B; Hellström-Lindberg E
Exp Hematol; 1999 Aug; 27(8):1322-9. PubMed ID: 10428509
[TBL] [Abstract][Full Text] [Related]
16. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells.
Josefsen D; Blomhoff HK; Lømo J; Blystad AK; Smeland EB
Exp Hematol; 1999 Apr; 27(4):642-53. PubMed ID: 10210322
[TBL] [Abstract][Full Text] [Related]
18. Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD.
Claessens YE; Park S; Dubart-Kupperschmitt A; Mariot V; Garrido C; Chrétien S; Dreyfus F; Lacombe C; Mayeux P; Fontenay M
Blood; 2005 May; 105(10):4035-42. PubMed ID: 15677568
[TBL] [Abstract][Full Text] [Related]
19. Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors.
Merchav S; Wagemaker G; Souza LM; Tatarsky I
Leukemia; 1991 Apr; 5(4):340-6. PubMed ID: 1709245
[TBL] [Abstract][Full Text] [Related]
20. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
